These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vancomycin- and erythromycin-induced hearing loss in humans. Brummett RE; Fox KE Antimicrob Agents Chemother; 1989 Jun; 33(6):791-6. PubMed ID: 2669623 [No Abstract] [Full Text] [Related]
7. Erythromycin-induced hypoacusis: 11 new cases and literature review. Sacristán JA; Soto JA; de Cos MA Ann Pharmacother; 1993; 27(7-8):950-5. PubMed ID: 8364281 [TBL] [Abstract][Full Text] [Related]
8. New developments in our understanding of ototoxicity. Roland PS Ear Nose Throat J; 2004 Sep; 83(9 Suppl 4):15-6; discussion 16-7. PubMed ID: 15543837 [No Abstract] [Full Text] [Related]
9. Irreversible sensorineural hearing loss due to erythromycin. Dylewski J CMAJ; 1988 Aug; 139(3):230-1. PubMed ID: 3395937 [No Abstract] [Full Text] [Related]
10. [Reversible hearing loss and erythromycin]. Rydberg J Lakartidningen; 1984 Mar; 81(13):1308. PubMed ID: 6708672 [No Abstract] [Full Text] [Related]
11. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity. Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367 [TBL] [Abstract][Full Text] [Related]
12. [Cochlear toxicity of erythromycin in elderly patients]. Hugues FC; Laccourreye A; Lasserre MH; Toupet M Therapie; 1984; 39(5):591-4. PubMed ID: 6506017 [No Abstract] [Full Text] [Related]
15. Erythromycin ototoxicity: analysis and conclusions based on 22 case reports. Haydon RC; Thelin JW; Davis WE Otolaryngol Head Neck Surg; 1984 Dec; 92(6):678-84. PubMed ID: 6440087 [TBL] [Abstract][Full Text] [Related]